Product

Company

Clareo Health | miRNA in Chronic Kidney Diseases

NCT06316284·1 site·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Josip Juraj Strossmayer University of Osijek

With

Age

18–69

Sex

ALL

Healthy volunteers

Accepted

healthy normotensive adults (eGFR CKD-EPI \>90 mL/min/1.73 m2, BP \<140/90 mmHg)
hypertensive adults (eGFR CKD-EPI \>90 mL/min/1.73 m2, BP \>140/90 mmHg)
patients with chronic kidney disease stage 3-5 (eGFR CKD-EPI\< 60 mL/min/1.73 m2)

The record

StatusNot yet recruiting

PhaseNo phase

Taking part90

StartedApr 2024

UpdatedMar 18, 2024

Conditions

Where1